nach oben

Erschienen in:

01.11.2023 | Media release

Omega-3-acid ethyl ester medicines: risk of AF in patients with established CV diseases or CV risk factors

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Heathcare professionals have been advised that use of omega-3-acid ethyl ester medicines can be associated with a dose-dependent increased risk of atrial fibrillation (AF) in patients with established cardiovascular (CV) diseases or CV risk factors. …

Health Products Regulatory Authority. Important Safety Information: Omega-3-acid ethyl ester medicines. Internet Document : 8 Nov 2023. Available from: URL: https://www.hpra.ie/docs/default-source/default-document-library/important-safety-information-omega-3-acid-ethyl-ester-medicines.pdf?sfvrsn=0

Titel: Omega-3-acid ethyl ester medicines: risk of AF in patients with established CV diseases or CV risk factors
Publikationsdatum: 01.11.2023
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-49352-x

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Omega-3-acid ethyl ester medicines: risk of AF in patients with established CV diseases or CV risk factors

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Non-serious case reports

Bortezomib/melphalan/prednisone

Antineoplastics

BCG vaccine

Multiple drugs interaction

Thrombomodulin alfa